Medical News

RSS

Visual collaboration makes its way into healthcare services

Evolving patients' needs, limited number of medical specialists in remote areas, and technological advances are some of the most important factors driving interest in visual collaboration in healthcare.

23 Mar 2010

EMA validates InterMune's pirfenidone MAA for IPF

InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is Esbriet®.

23 Mar 2010

Breathing diesel exhaust during pregnancy linked with sluggishness in offspring

Breathing diesel exhaust during pregnancy is associated with sluggishness in offspring. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology studied the effects of pollution exposure in mice, finding that the offspring of mothers who breathed diesel fumes while pregnant were less likely to show spontaneous movement.

23 Mar 2010

Alnylam Pharmaceuticals earns $20M technology transfer payment from Takeda Pharmaceutical

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.

23 Mar 2010

AOAC Research Institute validates MicroSEQ Salmonella spp. Detection Kit

Life Technologies Corporation today announced that its Applied Biosystems MicroSEQ® Salmonella spp. Detection Kit has been validated by the AOAC Research Institute for detection of the bacteria Salmonella.

23 Mar 2010

Walgreens's fiscal 2010 second-quarter sales up 3.1% to $17.0 billion

Walgreens today announced earnings and sales for the second quarter of fiscal year 2010.

23 Mar 2010

Merix Pharmaceutical introduces new Fast-Results! Genital Herpes Treatment

Merix Pharmaceutical Corp. unveiled its new Fast-Results!™ Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus.

23 Mar 2010

Aureus Pharma to participate in € 118 million BioIntelligence R&D programme

Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today it’s participation in a EUR118.2 million (USD 160 million) project. The project is the Biointelligence R&D programme designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.

23 Mar 2010

TAP, AVISO GmbH announce second distribution agreement to supply CellCelector stem cell picker

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, today announced it has entered into a second distribution agreement with AVISO GmbH, a major German manufacturer of automation for the stem cell market.

23 Mar 2010

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.

23 Mar 2010

CTSI licenses GeneGo's pathway analysis suite and database searching tool

GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute has licensed its pathway analysis suite MetaCore and its database searching tool Eureka.

23 Mar 2010

Inhibitex announces net loss of $4.7M for fourth-quarter 2009

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2009 and provided an update on various corporate developments.

23 Mar 2010

Report shows growth of the U.S. market for vascular access devices and accessories

According to a new global report series by iData Research, the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for vascular access devices and accessories was valued at just over $3 billion in 2009 and is estimated to reach over $4.6 billion by 2016.

23 Mar 2010

First Edition: March 23, 2010

Today's headlines cover a range of topics related to the newly passed health overhaul bill, from the surrounding opposition and next steps to some of its policy implications.

23 Mar 2010

Aradigm reports net loss of $3.4M for fourth-quarter 2009

Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009.

23 Mar 2010

E Cigarettes Choice to release limited edition of SS Choice STEALTH E-cigarette

E Cigarettes Choice announced today that they will release a limited edition of the SS Choice No.7 STEALTH, which they originally designed for the military. The STEALTH E-cigarette (Military Version) design was released to soldiers last summer and has been battle tested in Iraq and Afghanistan with overwhelming success.

23 Mar 2010

Skin sparing mastectomy procedures under-utilized in the U.S.

Joel A. Aronowitz, M.D., founder of the Breast Preservation Foundation and Division Clinical Chief of Plastic and Reconstructive Surgery at Cedars-Sinai Medical Center, recently led a group in Washington, D.C., to educate legislators and healthcare policy staff about the under-utilization of skin sparing mastectomy procedures in the U.S.

23 Mar 2010

WebIQ Pharma survey solution launched for pharmaceutical industry

Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment. Usability Sciences has provided usability and user experience research to Merck, Eli Lilly, Novartis and Ortho McNeil for over ten years.

23 Mar 2010

Providence Service Corporation remarks on passage of health care reform bill

The Providence Service Corporation today commented on last night's historical congressional action. The U.S. House of Representatives passed the Senate version of the health care reform bill as well as a reconciliation bill making some modifications to the original Senate act, called the Health Care and Education Affordability Reconciliation Act of 2010. The bills make a number of sweeping changes to Medicaid and insurance coverage for America's poor, a mission Providence has embraced since its inception in 1997.

23 Mar 2010